Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins

Published:2019-07-09 Issue:2 Volume:140 Page:138-146
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Ferdinand Keith C.¹,Balavoine Fabrice²,Besse Bruno²,Black Henry R.³,Desbrandes Stephanie²,Dittrich Howard C.⁴,Nesbitt Shawna D.⁵,

Affiliation:

1. Tulane University School of Medicine, New Orleans, LA (K.C.F.).

2. Quantum Genomics, Paris, France (F.B., B.B., S.D.).

3. New York University School of Medicine (H.R.B.).

4. Imager Consulting, Coronado, CA (H.C.D.).

5. University of Texas Southwestern Medical Center, Dallas (S.D.N.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017.;GBD 2017 Risk Factor Collaborators;Lancet,2018

2. The Relation of Adiposity to Blood Pressure and Development of Hypertension

3. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design, synthesis and pharmacological characterization of novel aminopeptidase A inhibitors;Bioorganic & Medicinal Chemistry Letters;2024-11

2. Options for patients with out-of-control blood pressure: after all avenues have been exhausted;Expert Review of Cardiovascular Therapy;2024-09-11

3. New therapeutic targets in hypertension;Medicina Clínica (English Edition);2024-09

4. New Kids on the Hypertension Block: Novel Agents With New Mechanisms of Action;American Journal of Hypertension;2024-08-14

5. Diagnosis and management of resistant hypertension;BMJ;2024-06-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3